Security key
29415J106
enVVeno Medical Corporation - Common Stock, $0.00001 par value (NVNO)
CUSIP: 29415J106
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, $0.00001 par value
- Shares outstanding
- 685,936
- Total 13F shares
- 1,812,147
- Share change
- +152,824
- Total reported value
- $8,498,422
- Price per share
- $4.68
- Number of holders
- 18
- Value change
- +$709,547
- Number of buys
- 8
- Number of sells
- 7
Report period
Q1 2023
Institutions
18
Top holders
10
NVNO full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
enVVeno Medical Corp SEC filings
enVVeno Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29415J106
Recent filing periods:
Top shareholders of NVNO - enVVeno Medical Corporation - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
114%
|
781,615
|
$3,986,236 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
49%
|
335,797
|
$1,712,564 | — | 31 Dec 2022 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
32%
|
219,180
|
$1,117,818 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
12%
|
83,083
|
$423,000 | — | 31 Dec 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
5.5%
|
37,960
|
$193,597 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.9%
|
33,810
|
$172,431 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
4.4%
|
30,430
|
$155,193 | — | 31 Dec 2022 | |
| ARTHUR M. COHEN & ASSOCIATES, LLC |
13F
|
Company |
3.5%
|
24,000
|
$122,400 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
3.1%
|
21,500
|
$109,650 | — | 31 Dec 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3.1%
|
21,493
|
$110,000 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
2.4%
|
16,377
|
$83,523 | — | 31 Dec 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.9%
|
13,300
|
$67,830 | — | 31 Dec 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
1.7%
|
11,350
|
$58,000 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.6%
|
11,087
|
$56,544 | — | 31 Dec 2022 | |
| Sepio Capital, LP |
13F
|
Company |
1.6%
|
10,800
|
$55,080 | — | 31 Dec 2022 | |
| Financial Perspectives, Inc |
13F
|
Company |
0.48%
|
3,278
|
$16,716 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.3%
|
2,059
|
$10,501 | — | 31 Dec 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.27%
|
1,858
|
$9,000 | — | 31 Dec 2022 | |
| EWG Elevate Inc. |
13F
|
Company |
0.05%
|
315
|
$1,607 | — | 31 Dec 2022 | |
| NFSG Corp |
13F
|
Company |
0%
|
20
|
$102 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
10
|
$51 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
1
|
$5 | — | 31 Dec 2022 |
Institutional Holders of enVVeno Medical Corporation - Common Stock, $0.00001 par value (NVNO) as of Q1 2023
As of 31 Mar 2023,
enVVeno Medical Corporation - Common Stock, $0.00001 par value (NVNO) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,812,147 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., UBS OCONNOR LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, and ARTHUR M. COHEN & ASSOCIATES, LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
22
Q1 2023 holders
18
Holder diff
-4
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.